Prevalence, characteristics, and publication of discontinued randomized trials.
about
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationWhy Most Clinical Research Is Not UsefulRecruitment and Screening for the Testosterone TrialsNon-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug TrialsImpact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study.Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for TerminationA population-based approach for implementing change from opt-out to opt-in research permissions.A systematic review of the processes used to link clinical trial registrations to their published resultsSubgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.Discontinuation and non-publication of surgical randomised controlled trials: observational study.Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review.Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D).Factors Associated with Clinical Research Recruitment in a Pediatric Academic Medical Center--A Web-Based Survey.Occurrence and determinants of selective reporting of clinical drug trials: design of an inception cohort studyVirtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.Planning and reporting of quality-of-life outcomes in cancer trials.Patient enrollment and logistical problems top the list of difficulties in clinical research: a cross-sectional survey.Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.Premature Discontinuation of Prospective Clinical Studies Approved by a Research Ethics Committee - A Comparison of Randomised and Non-Randomised StudiesAnimal Study Registries: Results from a Stakeholder Analysis on Potential Strengths, Weaknesses, Facilitators, and BarriersFate of registered clinical trials performed in Saudi ArabiaGenerating evidence on a risk-based monitoring approach in the academic setting - lessons learnedRecruiting for research studies using online public advertisements: examples from research in affective disorders.Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial.Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivorsItalian program for independent research on drugs: 10 year follow-up of funded studies in the area of rare diseases.Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.Results of a randomized, prospective, double-dummy, double-blind trial to compare efficacy and safety of a herbal combination containing Tropaeoli majoris herba and Armoraciae rusticanae radix with co-trimoxazole in patients with acute and uncomplicTowards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research qualityHealth researcher views on comparative effectiveness research and research engagement.Discontinuation and non-publication of randomised clinical trials supported by the main public funding body in Switzerland: a retrospective cohort study.Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).Improving site selection in clinical studies: a standardised, objective, multistep method and first experience results.Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.Methods and impact of engagement in research, from theory to practice and back again: early findings from the Patient-Centered Outcomes Research Institute.Public preferences on written informed consent for low-risk pragmatic clinical trials in Spain.The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysisAttitudes toward Potential Participant Registries.
P2860
Q24193614-4ACF6F2E-6C8A-40B5-9AE8-3BC6A45C20EEQ24707972-5DF121E4-AFF8-41B8-8BA8-84DE34B8534FQ27301479-B91223A3-30C5-48CC-A125-3CA24584A4FCQ28555016-A1576B2F-1AB3-4569-A334-FA6FABF6885DQ30871934-37A1D96D-1B28-435F-BEC5-08CFCD170C9FQ30958675-9940E585-CB2B-4C08-9722-23A950410370Q33602661-E82C6D15-0E8A-44AE-84FE-BA9B54B56ADDQ33864361-A9BC8AA9-9D27-46D6-89AF-DB89FE1B37B9Q33909616-A987E777-B5E7-4C06-A8D3-7C9038606A05Q34452911-7980AB45-B5E3-4829-8D30-C4D62CDF4454Q34728846-F6FE7583-FBB9-4D52-BC56-7C111231E000Q35205110-EB4CE721-8757-4437-8B2B-26C809288406Q35810170-7347F9BA-E3A9-4352-8695-49D7EB349B23Q35844255-D9E0DE92-87B5-421A-B277-CCAA8DF254EEQ35844749-F32ACDE8-01AA-4AEB-B36C-E22F4450F27AQ36000225-07101704-07EB-4530-ABB5-B0E44ECF9A74Q36008577-745D9D1A-6FB9-48A0-9118-5A011CD4DC8FQ36166127-99B28209-DEF5-4B6B-8B9E-DDFC17378FB9Q36177178-DC3926A0-A621-4046-B13A-7B59C1AED911Q36188560-B551A858-E5A9-4CFF-8E84-F23DFF4E02B5Q36210327-485C6ECD-F8E6-4786-8E07-1059870DD4E7Q36279006-2A6A8FC9-45E1-467D-A0A9-15D40419B9D3Q36575279-071BB8B6-E9FA-423B-A848-748390EAEB62Q36673516-8C82E1C3-6BD2-4F2A-B75D-CF23C86155D1Q36715240-187325FD-5FE2-4756-9744-033207F2A28FQ36757714-6047A492-D3D5-4BD1-AB80-A0C8189C30D2Q36790524-9F6ECC4A-3C10-4BB6-B3EA-F733908E14FEQ36819100-1F880858-389A-4C6A-8457-0B3992229174Q37046876-B070581E-EDCA-40E5-97ED-4BDA77B153DEQ37712373-D78356E9-F610-4787-85C3-E6201823471DQ38369704-1232C1E3-EE62-40EB-8C51-A671B7392942Q38373452-20D24D64-15EF-4A0D-A1F1-5EC2A057FD44Q38648127-CBBF0A63-249A-437A-AAE3-288B7FE75EB7Q38663993-0D9BE293-5E1E-4CA4-802F-B9B55CEF38DAQ38680041-3BE89B84-DBFC-47FC-932B-3A0CF9AE1EB6Q38759291-3475BD6E-B1B9-479B-817D-D6C0E45994F4Q38788407-96D99474-D1D4-4F33-802B-D214FE0AF8C8Q38832151-211AF372-2140-410B-BC8E-32C3A97B070EQ38908683-D9E5C6B2-7686-4C52-9BC9-90A6EEAAC97AQ39010379-BC045328-5FEB-491A-B4A2-D8187509A31E
P2860
Prevalence, characteristics, and publication of discontinued randomized trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prevalence, characteristics, and publication of discontinued randomized trials.
@en
type
label
Prevalence, characteristics, and publication of discontinued randomized trials.
@en
prefLabel
Prevalence, characteristics, and publication of discontinued randomized trials.
@en
P2093
P50
P356
P1476
Prevalence, characteristics, and publication of discontinued randomized trials.
@en
P2093
Alain Amstutz
Alain Nordmann
Alonso Carrasco-Labra
Benjamin Kasenda
Bernard Burnand
Bradley C Johnston
Dirk Bassler
Dominik Mertz
Elie A Akl
Francois Lamontagne
P304
P356
10.1001/JAMA.2014.1361
P407
P50
P577
2014-03-01T00:00:00Z